Orbimed Advisors LLC Morphic Holding, Inc. Put Options Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MORF
# of Institutions
68Shares Held
27.6MCall Options Held
4.2KPut Options Held
200K-
Black Rock Inc. New York, NY3.53MShares$201 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA1.78MShares$102 Million0.61% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.46MShares$83.3 Million0.14% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.06MShares$60.5 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il162KShares$9.23 Million0.0% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $2.19B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...